Chemotherapy induced changes to fibrin clots properties in lung cancer: is it favorable? | Zendy

Mitsuo Sato | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Chemotherapy induced changes to fibrin clots properties in lung cancer: is it favorable?

Author(s) -

Mitsuo Sato

Publication year - 2019

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2019.04.103

Subject(s) - medicine , venous thromboembolism , lung cancer , cancer , thrombosis , fibrin , chemotherapy , intensive care medicine , venous thrombosis , oncology , immunology

Patients with cancer are frequently in a hypercoagulable state and the reported incidences of venous thromboembolism (VTE) and arterial thrombosis in patients with cancer are 4–20% and 2–5%, respectively (1-3). In particular, VTE is associated with worse prognosis in patients with cancer (4,5); therefore, extensive investigations have been performed for the development of useful risk assessment models, identification of better VTE biomarkers, and exploration of efficient therapeutic interventions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research